Author:
Tybjærg-Hansen Anne,Nordestgaard Børge Grønne
Reference122 articles.
1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;Circulation,2019
2. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020
3. 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults;Pearson;Can J Cardiol,2021
4. Cardiovascular Disease: Risk Assessment and Reduction, Including Lipid Modification,2016
5. Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation;Hoogeveen;Clin Chem,2021